Tyler Curiel
Professor of Medicine · Geisel School of Medicine
Credentials: · · · · · · ·
History
- Present
- Present
- 1987–1989
Medical Oncology
- 1982–1985
Yale Medical School & Yale-New Haven Hospital
1978–1982
Research
Nature Medicine · 2004 · First of 21 authors · 4,118 citations
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Nature Medicine · 2003 · First of 22 authors · 1,061 citations
Nature Medicine · 1995 · 781 citations
18 papers
13 papers
- RV
12 papers · 2 as a fellow
9 papers · 1 as a resident
- AK
8 papers · 3 as a resident
- CC
8 papers · 4 as a resident
- JD
8 papers · 3 as a resident
- PC
8 papers
Grants
- 2024–2029
Melanocyte PDL1 Control of UVB-Induced IFN-I
National Cancer Institute · R01
Contact PI · $1.9M · Dartmouth-Hitchcock Clinic
- 2024–2029
Adipocyte PD-L1 in the Breast Tumor Microenvironment
National Cancer Institute · R01
PI · $2M · George Washington University
- 2022–2028
National Cancer Institute · R01
Contact PI · $2.5M · Dartmouth-Hitchcock Clinic
- 2018–2024
(PQ2) PD-L1/PD-1 Signals in Aged Hosts Undergoing Cancer Immunotherapy
National Cancer Institute · R01
Contact PI · $3.1M · Dartmouth-Hitchcock Clinic
Clinical trials
- 2017–2018
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Principal investigator · Withdrawn
The University of Texas Health Science Center at San Antonio
- 2012–2015
Principal investigator · Completed · Phase 1
The University of Texas Health Science Center at San Antonio
- 2009–2011
Principal investigator · Terminated · Phase 2
The University of Texas Health Science Center at San Antonio
- 2007–2010
A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer
Principal investigator · Completed · Phase 2
The University of Texas Health Science Center at San Antonio